Cathy N Lam

Array ( [id] => 11766906 [patent_doc_number] => 09375422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Fentanyl-containing adhesive preparation for external use' [patent_app_type] => utility [patent_app_number] => 13/319169 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3330 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017003 [patent_doc_number] => 20110224311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Natural Product Sweetness Enhancers' [patent_app_type] => utility [patent_app_number] => 12/838278 [patent_app_country] => US [patent_app_date] => 2010-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17736 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224311.pdf [firstpage_image] =>[orig_patent_app_number] => 12838278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149932 [patent_doc_number] => 20110021527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'DUAL-ACTING OXAZOLE ANTIHYPERTENSIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/835999 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25617 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021527.pdf [firstpage_image] =>[orig_patent_app_number] => 12835999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136720 [patent_doc_number] => 20110009410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'APOPTOSIS SIGNAL-REGULATING KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/834673 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 64903 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009410.pdf [firstpage_image] =>[orig_patent_app_number] => 12834673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199317 [patent_doc_number] => 20120122773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/380376 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88601 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122773.pdf [firstpage_image] =>[orig_patent_app_number] => 13380376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898131 [patent_doc_number] => 08921345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Pharmaceutical composition for emergency contraception' [patent_app_type] => utility [patent_app_number] => 13/377809 [patent_app_country] => US [patent_app_date] => 2010-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6058 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211666 [patent_doc_number] => 20120129949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Use of Anthracene Derivatives as Anti-Infectives' [patent_app_type] => utility [patent_app_number] => 13/375059 [patent_app_country] => US [patent_app_date] => 2010-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3786 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129949.pdf [firstpage_image] =>[orig_patent_app_number] => 13375059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496506 [patent_doc_number] => 20120295914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'COMBINATION OF ADRENERGIC RECEPTOR AGONIST ALPHA-1 OR ALPHA-2, PREFERABLY BRIMONIDINE WITH FILLERS, PREFERABLY HYALURONIC ACID' [patent_app_type] => utility [patent_app_number] => 13/322245 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4015 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6352432 [patent_doc_number] => 20100331364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'TREATMENT OF HFnEF' [patent_app_type] => utility [patent_app_number] => 12/785077 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9550 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331364.pdf [firstpage_image] =>[orig_patent_app_number] => 12785077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267406 [patent_doc_number] => 20100298362 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'PROCESS FOR THE PREPARATION OF 4-[6-(6-METHANESULFONYL-2-METHYL-PYRIDIN-3-YLAMINO)-5-METHOXY-PYRIMIDIN-4-YLOXY]-PIPERIDINE-1-CARBOXYLIC ACID ISOPROPYL ESTER' [patent_app_type] => utility [patent_app_number] => 12/783927 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12350 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298362.pdf [firstpage_image] =>[orig_patent_app_number] => 12783927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8721335 [patent_doc_number] => 20130072552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'CRYSTALLINE HYDROCHLORIDE SALT OF DARUNAVIR' [patent_app_type] => utility [patent_app_number] => 13/699096 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2801 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6389129 [patent_doc_number] => 20100317738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH NEURONAL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 12/781282 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10830 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317738.pdf [firstpage_image] =>[orig_patent_app_number] => 12781282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929865 [patent_doc_number] => 20110039824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => '1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors' [patent_app_type] => utility [patent_app_number] => 12/662971 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25650 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039824.pdf [firstpage_image] =>[orig_patent_app_number] => 12662971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952235 [patent_doc_number] => 20110033393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Hydrazone Compounds and Their Use' [patent_app_type] => utility [patent_app_number] => 12/778906 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 44503 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033393.pdf [firstpage_image] =>[orig_patent_app_number] => 12778906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599943 [patent_doc_number] => 20100292279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Bis-(Sulfonylamino) Derivatives in Therapy' [patent_app_type] => utility [patent_app_number] => 12/778355 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37289 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292279.pdf [firstpage_image] =>[orig_patent_app_number] => 12778355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6598622 [patent_doc_number] => 20100292222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'CHEMICAL COMPOUNDS 751' [patent_app_type] => utility [patent_app_number] => 12/776970 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 33851 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292222.pdf [firstpage_image] =>[orig_patent_app_number] => 12776970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497831 [patent_doc_number] => 20100286155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'ADRENOCORTICAL CARCINOMA TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/775556 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 1718 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286155.pdf [firstpage_image] =>[orig_patent_app_number] => 12775556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8081087 [patent_doc_number] => 08147863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Polyarylates for drug delivery and tissue engineering' [patent_app_type] => utility [patent_app_number] => 12/773954 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7579 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/147/08147863.pdf [firstpage_image] =>[orig_patent_app_number] => 12773954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500650 [patent_doc_number] => 20100286260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'MILNACIPRAN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/774446 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32005 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286260.pdf [firstpage_image] =>[orig_patent_app_number] => 12774446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689998 [patent_doc_number] => 08389525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Small molecules for inhibition of protein kinases' [patent_app_type] => utility [patent_app_number] => 12/774230 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 13001 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12774230 [rel_patent_id] =>[rel_patent_doc_number] =>)